In the last year, some drugmakers have pulled back from the sector, including Pfizer, which recently stopped selling its gene ...

Along with partner Vertex Pharmaceuticals, it has won regulatory approval for Casgevy, a revolutionary treatment for SCD and beta-thalassemia. Meanwhile, Intellia is partnered with Regeneron ...

When it comes to recipes, I have a few nonnegotiables: simple, healthy and delicious! These creations are terrific for when you’re craving a quick breakfast or scrumptious afternoon snack: my ...

Optum Rx, is the pharmacy benefit manager owned by UnitedHealth Group Inc’s UNH Also Read: HHS Challenges Vertex Over Fertility Services Program Tied To Casgevy Gene Therapy, Says Company Is ...

It was the first company to receive FDA approval, in December 2023, for Casgevy – a genome-edited cell therapy for sickle-cell disease and another blood disorder, beta thalassaemia. These are ...

Or take Casgevy, the first CRISPR-approved medicine developed by Vertex and CRISPR Therapeutics and approved in December 2023. Critical to the development of the fetal hemoglobin switching ...

An icon of 3 horizontal dots. An icon of a paper envelope. An icon of a facebook f logo. An icon of a digital camera. An icon of a house. An icon of the Instagram logo. An icon of the LinkedIn logo.

CRISPR Therapeutics, a pioneering biotechnology company specializing in gene-editing therapeutics, showcased strong momentum in late 2023 with the approval of Casgevy, its groundbreaking treatment for ...

CRISPR Therapeutics, a pioneering biotechnology company specializing in gene-editing therapeutics, showcased strong momentum in late 2023 with the approval of Casgevy, its groundbreaking treatment ...

On 31 January the NHS announced the approval CASGEVY, the first CRISPR gene therapy treatment for sickle cell disease. It will be offered at specialist NHS centres to treat patients who experience ...